Investigating the Neuropsychological Effects of 5-HT2a Antagonism
NCT07022366
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Pimavanserin 10mg
DRUG:
Placebo
Sponsor
University of Oxford